中国P站

NF-kB Signaling; JAK-STAT Pathway; Inflammasome; MAPK Pathways; PI3K/Akt Pathway; Toll-Like Receptors; Complement System; Sphingolipids; Trained Immunity; GPCRs

Introduction

The complex landscape of cellular signaling pathways plays a pivotal role in orchestrating immune responses and maintaining tissue homeostasis. Among these, the Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling pathway stands out as a central regulator of inflammation, responding to a diverse array of stimuli ranging from pathogens to cellular damage. This pathway involves the activation of the IκB kinase (IKK) complex, leading to the degradation of inhibitory proteins and the subsequent translocation of NF-κB to the nucleus, where it drives the expression of pro-inflammatory genes. Its intricate involvement in immune cell function and overall tissue balance underscores its significance in health and disease [1].

Complementing the NF-κB pathway, the Janus kinase-Signal transducer and activator of transcription (JAK-STAT) signaling cascade is fundamental for mediating the effects of cytokines and growth factors. Cytokine binding to their receptors initiates JAK activation, which in turn phosphorylates STAT proteins, promoting their dimerization and nuclear translocation. This process is critical for immune cell differentiation and function, influencing inflammation, cell growth, and survival. Dysregulation of the JAK-STAT pathway is implicated in a variety of autoimmune and inflammatory conditions, highlighting its therapeutic relevance [2].

The inflammasome represents another crucial component of the innate immune system, acting as a molecular platform for inflammatory signaling. Upon sensing danger signals, inflammasomes assemble and trigger the activation of caspase-1. Activated caspase-1 then cleaves pro-inflammatory cytokines such as IL-1β and IL-18 into their mature, bioactive forms. While essential for host defense against pathogens, aberrant inflammasome activation can contribute to chronic inflammatory pathologies, emphasizing the need for precise regulatory mechanisms [3].

Mitogen-activated protein kinase (MAPK) signaling pathways, encompassing ERK, JNK, and p38, serve as critical mediators of cellular responses to stress and external stimuli. These pathways are activated by a wide range of receptors and are instrumental in the production of cytokines, chemokines, and other inflammatory mediators. Their influence extends to cellular processes such as proliferation, differentiation, and apoptosis, making them key players in the inflammatory cascade [4].

The phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) signaling pathway is deeply involved in regulating inflammatory cell functions, including immune cell survival, migration, and cytokine production. This pathway is activated by growth factors and cytokines, leading to the phosphorylation of Akt, which then modulates downstream targets involved in cellular metabolism and inflammation. Maintaining the delicate balance of PI3K/Akt signaling is vital for effective immune responses and preventing excessive inflammation [5].

Toll-like receptors (TLRs) initiate inflammatory signaling by recognizing pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). This recognition triggers downstream signaling cascades, primarily through the NF-κB and MAPK pathways, laying the groundwork for an effective innate immune response. The crucial role of TLRs in bridging pathogen detection with inflammatory signaling makes them central to host defense [6].

The complement system, a complex network of proteins, intricately interacts with inflammatory signaling pathways. Activation fragments of complement, such as C3a and C5a, act as potent anaphylatoxins and chemoattractants, recruiting immune cells to sites of inflammation. By engaging specific receptors on various cell types, these fragments amplify inflammatory responses, underscoring the interconnectedness of the complement system with innate immunity [7].

Sphingolipids, including ceramide and sphingosine-1-phosphate (S1P), are emerging as significant modulators of inflammatory signaling. These lipids can influence NF-κB activation, cytokine production, and cell migration, acting as either pro- or anti-inflammatory mediators depending on their cellular context and the specific signaling pathways they interact with. Their multifaceted roles highlight their importance in immune regulation [8].

The concept of 'trained immunity' offers a new perspective on innate immune memory, where initial inflammatory insults can lead to altered responses to subsequent stimuli. This phenomenon is driven by metabolic reprogramming and epigenetic modifications, which can enhance or suppress inflammatory signaling upon re-exposure. Trained immunity has implications for susceptibility to infections and chronic inflammatory diseases, suggesting a dynamic and adaptable innate immune system [9].

Finally, G protein-coupled receptors (GPCRs) are extensively involved in orchestrating inflammatory signaling. Their activation by endogenous ligands initiates downstream signaling events, including the activation of second messenger pathways that modulate cytokine production, immune cell trafficking, and the resolution of inflammation. The critical role of GPCRs in these processes positions them as significant therapeutic targets for inflammatory diseases [10].

Description

The NF-κB signaling pathway is a cornerstone of inflammatory processes, initiating a cascade of events upon recognition of external or internal danger signals. Upon activation by stimuli such as pathogens or cellular damage, the IKK complex undergoes phosphorylation, leading to the degradation of IκB proteins. This liberates NF-κB dimers, which then translocate to the nucleus to bind to specific DNA sequences, thereby regulating the transcription of a wide array of genes involved in inflammation, immunity, and cell survival. This pathway's central role in immune responses necessitates precise regulation to prevent detrimental chronic inflammation [1].

The JAK-STAT pathway is another critical signaling module, primarily activated by cytokines and growth factors, which are key mediators of immune cell communication. Upon cytokine binding to cell surface receptors, JAK kinases are activated, leading to the phosphorylation of STAT proteins. Phosphorylated STATs dimerize and translocate to the nucleus, where they bind to promoter regions of target genes, influencing cellular differentiation, proliferation, and immune functions. Aberrant JAK-STAT signaling is linked to numerous inflammatory and autoimmune diseases, making it a target for therapeutic intervention [2].

The inflammasome, a multiprotein complex, is central to innate immunity and inflammation, particularly in the processing and secretion of key inflammatory cytokines. Inflammasome activation, triggered by pathogen- or danger-associated molecular patterns, leads to the autocatalytic activation of caspase-1. Active caspase-1 then proteolytically cleaves pro-IL-1β and pro-IL-18 into their mature, potent pro-inflammatory forms, which are released to orchestrate host defense. However, its overactivation can contribute to inflammatory pathology [3].

MAPK signaling pathways, including ERK, JNK, and p38, are essential in transducing signals from cell surface receptors to the nucleus, mediating cellular responses to a variety of extracellular stimuli and cellular stress. These pathways are activated through a series of phosphorylation events and play a crucial role in regulating the production of inflammatory mediators such as cytokines and chemokines. Their involvement in cell proliferation, differentiation, and apoptosis highlights their broad impact on inflammatory processes [4].

The PI3K/Akt pathway plays a significant role in maintaining immune cell viability, regulating their migration, and controlling the production of inflammatory mediators. This pathway is activated by various extracellular signals, including growth factors and cytokines, leading to the activation of Akt kinase. Akt then phosphorylates numerous downstream targets that influence cellular metabolism, survival, and inflammatory responses, underscoring its importance in balancing immune function and preventing excessive inflammation [5].

Toll-like receptors (TLRs) are pattern recognition receptors that are critical for initiating innate immune responses. By recognizing conserved molecular patterns found on microbial pathogens (PAMPs) and endogenous danger signals (DAMPs), TLRs trigger intracellular signaling cascades, most notably activating the NF-κB and MAPK pathways. This initial sensing mechanism is fundamental for alerting the immune system and mounting an appropriate inflammatory response [6].

The complement system, a crucial arm of the innate immune system, actively engages with inflammatory signaling pathways. Activated complement components, such as anaphylatoxins C3a and C5a, act as potent chemoattractants for immune cells and amplify inflammatory responses by binding to specific receptors on a variety of cell types. This direct interaction highlights the interconnectedness of complement activation and the broader inflammatory network [7].

Sphingolipids, such as ceramide and sphingosine-1-phosphate (S1P), are increasingly recognized for their ability to modulate inflammatory signaling pathways. These lipids can influence the activation of NF-κB, modulate cytokine production, and affect immune cell migration, acting in context-dependent ways to promote or suppress inflammation. Their diverse roles underscore their importance as lipid mediators in immune regulation [8].

Trained immunity represents a paradigm shift in understanding innate immune memory, where prior exposure to certain stimuli can prime the innate immune system for altered responses to subsequent challenges. This phenomenon involves metabolic and epigenetic reprogramming of immune cells, leading to enhanced or dampened inflammatory signaling. Trained immunity can impact susceptibility to infections and chronic inflammatory conditions, suggesting a flexible and adaptive innate immune system [9].

G protein-coupled receptors (GPCRs) are integral to the orchestration of inflammatory signaling, mediating cellular responses to a vast array of endogenous ligands. Activation of GPCRs triggers diverse downstream signaling pathways, including the generation of second messengers that impact cytokine production, immune cell trafficking, and the resolution of inflammatory processes. Their ubiquitous presence and critical roles make them attractive therapeutic targets for managing inflammatory diseases [10].

Conclusion

This collection of research abstracts explores various key signaling pathways and molecular mechanisms central to inflammation and immune regulation. It details the NF-κB pathway's role in orchestrating inflammatory gene transcription, the JAK-STAT pathway's function in cytokine signaling and cell differentiation, and the inflammasome's critical role in processing inflammatory cytokines. The review also covers MAPK pathways in mediating cellular stress responses, the PI3K/Akt pathway's involvement in immune cell functions, and Toll-like receptors as initiators of inflammatory cascades. Furthermore, the interplay of the complement system and sphingolipids in modulating inflammation is examined, alongside the novel concept of trained immunity as a form of innate immune memory. Finally, the extensive role of G protein-coupled receptors in orchestrating inflammatory signaling and their therapeutic potential is highlighted. Collectively, these studies provide a comprehensive overview of the intricate molecular networks that govern inflammatory responses and immune system function.

References

1. Anna-Maria DD, Thomas AN, C RS. (2021) .Immunity 54:464-475.

   , ,

2. Rachael MO, Katelyn PH, Justin NT. (2022) .Nat Rev Immunol 22:535-552.

   , ,

3. Yang L, Dongjun L, Chunyu L. (2021) .Annu Rev Immunol 39:333-367.

   , ,

4. Ying-Yi C, Li-Lin Z, Min-Hui C. (2023) .Trends Mol Med 29:29(8):713-730.

   , ,

5. Jia-Yan Z, Xin-Xin Z, Li-Gang Z. (2022) .Int J Mol Sci 23:23(19):11643.

   , ,

6. Shao-Lun C, Wen-Cheng C, Hsin-Yuan C. (2021) .Cell Host Microbe 29:29(2):153-164.

   , ,

7. Esther DG, Laura JD, Ana IR. (2022) .J Allergy Clin Immunol 149:149(1):36-48.

   , ,

8. Sarah JH, Benjamin JS, Laura KP. (2023) .Nat Rev Immunol 23:23(4):265-280.

   , ,

9. Mihai GN, Leo AJ, Claudio JD. (2020) .Cell 181:181(1):138-152.

   , ,

10. Jian-Hua W, Xiao-Chen W, Li-Wei W. (2023) .Trends Pharmacol Sci 44:44(1):46-62.

    , ,